![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-6988|3|2|75-75
ISSN: 2212-697x
Source: Clinical Cancer Drugs, Vol.3, Iss.2, 2016-10, pp. : 75-75
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmaceutical Nanotechnology, Vol. 3, Iss. 1, 2015-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Drug Delivery, Vol. 14, Iss. 4, 2017-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Cancer Drugs, Vol. 4, Iss. 1, 2017-05 ,pp. :